Global Swine Mycoplasma Vaccine Market Growth 2026-2032
The global Swine Mycoplasma Vaccine market size is predicted to grow from US$ 798 million in 2025 to US$ 1362 million in 2032; it is expected to grow at a CAGR of 8.1% from 2026 to 2032.
Swine mycoplasma vaccine is a type of vaccine that is designed to prevent mycoplasma infections in pigs. Mycoplasmas are bacteria that can cause a variety of respiratory and reproductive diseases in pigs, such as enzootic pneumonia, arthritis, and urinary tract infections.
United States market for Swine Mycoplasma Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Swine Mycoplasma Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Swine Mycoplasma Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Swine Mycoplasma Vaccine players cover Zoetis, Boehringer Ingelheim, Jinhe Biotechnology, Merck, HIPRA, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Swine Mycoplasma Vaccine Industry Forecast” looks at past sales and reviews total world Swine Mycoplasma Vaccine sales in 2025, providing a comprehensive analysis by region and market sector of projected Swine Mycoplasma Vaccine sales for 2026 through 2032. With Swine Mycoplasma Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Swine Mycoplasma Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Swine Mycoplasma Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Swine Mycoplasma Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Swine Mycoplasma Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Swine Mycoplasma Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Swine Mycoplasma Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Swine Mycoplasma Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Swine Mycoplasma Vaccine market?
What factors are driving Swine Mycoplasma Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Swine Mycoplasma Vaccine market opportunities vary by end market size?
How does Swine Mycoplasma Vaccine break out by Type, by Application?
Swine mycoplasma vaccine is a type of vaccine that is designed to prevent mycoplasma infections in pigs. Mycoplasmas are bacteria that can cause a variety of respiratory and reproductive diseases in pigs, such as enzootic pneumonia, arthritis, and urinary tract infections.
United States market for Swine Mycoplasma Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Swine Mycoplasma Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Swine Mycoplasma Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Swine Mycoplasma Vaccine players cover Zoetis, Boehringer Ingelheim, Jinhe Biotechnology, Merck, HIPRA, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Swine Mycoplasma Vaccine Industry Forecast” looks at past sales and reviews total world Swine Mycoplasma Vaccine sales in 2025, providing a comprehensive analysis by region and market sector of projected Swine Mycoplasma Vaccine sales for 2026 through 2032. With Swine Mycoplasma Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Swine Mycoplasma Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Swine Mycoplasma Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Swine Mycoplasma Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Swine Mycoplasma Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Swine Mycoplasma Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Swine Mycoplasma Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Swine Mycoplasma Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Inactivated Vaccines
- Live Vaccines
- Piglets
- Adult Pigs
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Zoetis
- Boehringer Ingelheim
- Jinhe Biotechnology
- Merck
- HIPRA
- Ceva Sant? Animale
- Harbin Pharmaceutical Group
- Pulike Biotech
- Qilu Animal Health Products
- Wuhan Keqian Biology
- Guangdong Winsun Bio-Pharmaceutical
What is the 10-year outlook for the global Swine Mycoplasma Vaccine market?
What factors are driving Swine Mycoplasma Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Swine Mycoplasma Vaccine market opportunities vary by end market size?
How does Swine Mycoplasma Vaccine break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Swine Mycoplasma Vaccine Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Swine Mycoplasma Vaccine by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Swine Mycoplasma Vaccine by Country/Region, 2021, 2025 & 2032
2.2 Swine Mycoplasma Vaccine Segment by Type
2.2.1 Inactivated Vaccines
2.2.2 Live Vaccines
2.2.3 Swine Mycoplasma Vaccine Sales by Type
2.2.3.1 Global Swine Mycoplasma Vaccine Sales Market Share by Type (2021-2026)
2.2.3.2 Global Swine Mycoplasma Vaccine Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Swine Mycoplasma Vaccine Sale Price by Type (2021-2026)
2.3 Swine Mycoplasma Vaccine Segment by Application
2.3.1 Piglets
2.3.2 Adult Pigs
2.3.3 Swine Mycoplasma Vaccine Sales by Application
2.3.3.1 Global Swine Mycoplasma Vaccine Sale Market Share by Application (2021-2026)
2.3.3.2 Global Swine Mycoplasma Vaccine Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Swine Mycoplasma Vaccine Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Swine Mycoplasma Vaccine Breakdown Data by Company
3.1.1 Global Swine Mycoplasma Vaccine Annual Sales by Company (2021-2026)
3.1.2 Global Swine Mycoplasma Vaccine Sales Market Share by Company (2021-2026)
3.2 Global Swine Mycoplasma Vaccine Annual Revenue by Company (2021-2026)
3.2.1 Global Swine Mycoplasma Vaccine Revenue by Company (2021-2026)
3.2.2 Global Swine Mycoplasma Vaccine Revenue Market Share by Company (2021-2026)
3.3 Global Swine Mycoplasma Vaccine Sale Price by Company
3.4 Key Manufacturers Swine Mycoplasma Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Swine Mycoplasma Vaccine Product Location Distribution
3.4.2 Players Swine Mycoplasma Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR SWINE MYCOPLASMA VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Swine Mycoplasma Vaccine Market Size by Geographic Region (2021-2026)
4.1.1 Global Swine Mycoplasma Vaccine Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Swine Mycoplasma Vaccine Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Swine Mycoplasma Vaccine Market Size by Country/Region (2021-2026)
4.2.1 Global Swine Mycoplasma Vaccine Annual Sales by Country/Region (2021-2026)
4.2.2 Global Swine Mycoplasma Vaccine Annual Revenue by Country/Region (2021-2026)
4.3 Americas Swine Mycoplasma Vaccine Sales Growth
4.4 APAC Swine Mycoplasma Vaccine Sales Growth
4.5 Europe Swine Mycoplasma Vaccine Sales Growth
4.6 Middle East & Africa Swine Mycoplasma Vaccine Sales Growth
5 AMERICAS
5.1 Americas Swine Mycoplasma Vaccine Sales by Country
5.1.1 Americas Swine Mycoplasma Vaccine Sales by Country (2021-2026)
5.1.2 Americas Swine Mycoplasma Vaccine Revenue by Country (2021-2026)
5.2 Americas Swine Mycoplasma Vaccine Sales by Type (2021-2026)
5.3 Americas Swine Mycoplasma Vaccine Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Swine Mycoplasma Vaccine Sales by Region
6.1.1 APAC Swine Mycoplasma Vaccine Sales by Region (2021-2026)
6.1.2 APAC Swine Mycoplasma Vaccine Revenue by Region (2021-2026)
6.2 APAC Swine Mycoplasma Vaccine Sales by Type (2021-2026)
6.3 APAC Swine Mycoplasma Vaccine Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Swine Mycoplasma Vaccine by Country
7.1.1 Europe Swine Mycoplasma Vaccine Sales by Country (2021-2026)
7.1.2 Europe Swine Mycoplasma Vaccine Revenue by Country (2021-2026)
7.2 Europe Swine Mycoplasma Vaccine Sales by Type (2021-2026)
7.3 Europe Swine Mycoplasma Vaccine Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Swine Mycoplasma Vaccine by Country
8.1.1 Middle East & Africa Swine Mycoplasma Vaccine Sales by Country (2021-2026)
8.1.2 Middle East & Africa Swine Mycoplasma Vaccine Revenue by Country (2021-2026)
8.2 Middle East & Africa Swine Mycoplasma Vaccine Sales by Type (2021-2026)
8.3 Middle East & Africa Swine Mycoplasma Vaccine Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Swine Mycoplasma Vaccine
10.3 Manufacturing Process Analysis of Swine Mycoplasma Vaccine
10.4 Industry Chain Structure of Swine Mycoplasma Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Swine Mycoplasma Vaccine Distributors
11.3 Swine Mycoplasma Vaccine Customer
12 WORLD FORECAST REVIEW FOR SWINE MYCOPLASMA VACCINE BY GEOGRAPHIC REGION
12.1 Global Swine Mycoplasma Vaccine Market Size Forecast by Region
12.1.1 Global Swine Mycoplasma Vaccine Forecast by Region (2027-2032)
12.1.2 Global Swine Mycoplasma Vaccine Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Swine Mycoplasma Vaccine Forecast by Type (2027-2032)
12.7 Global Swine Mycoplasma Vaccine Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Zoetis
13.1.1 Zoetis Company Information
13.1.2 Zoetis Swine Mycoplasma Vaccine Product Portfolios and Specifications
13.1.3 Zoetis Swine Mycoplasma Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Zoetis Main Business Overview
13.1.5 Zoetis Latest Developments
13.2 Boehringer Ingelheim
13.2.1 Boehringer Ingelheim Company Information
13.2.2 Boehringer Ingelheim Swine Mycoplasma Vaccine Product Portfolios and Specifications
13.2.3 Boehringer Ingelheim Swine Mycoplasma Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Boehringer Ingelheim Main Business Overview
13.2.5 Boehringer Ingelheim Latest Developments
13.3 Jinhe Biotechnology
13.3.1 Jinhe Biotechnology Company Information
13.3.2 Jinhe Biotechnology Swine Mycoplasma Vaccine Product Portfolios and Specifications
13.3.3 Jinhe Biotechnology Swine Mycoplasma Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Jinhe Biotechnology Main Business Overview
13.3.5 Jinhe Biotechnology Latest Developments
13.4 Merck
13.4.1 Merck Company Information
13.4.2 Merck Swine Mycoplasma Vaccine Product Portfolios and Specifications
13.4.3 Merck Swine Mycoplasma Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Merck Main Business Overview
13.4.5 Merck Latest Developments
13.5 HIPRA
13.5.1 HIPRA Company Information
13.5.2 HIPRA Swine Mycoplasma Vaccine Product Portfolios and Specifications
13.5.3 HIPRA Swine Mycoplasma Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 HIPRA Main Business Overview
13.5.5 HIPRA Latest Developments
13.6 Ceva Sant? Animale
13.6.1 Ceva Sant? Animale Company Information
13.6.2 Ceva Sant? Animale Swine Mycoplasma Vaccine Product Portfolios and Specifications
13.6.3 Ceva Sant? Animale Swine Mycoplasma Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Ceva Sant? Animale Main Business Overview
13.6.5 Ceva Sant? Animale Latest Developments
13.7 Harbin Pharmaceutical Group
13.7.1 Harbin Pharmaceutical Group Company Information
13.7.2 Harbin Pharmaceutical Group Swine Mycoplasma Vaccine Product Portfolios and Specifications
13.7.3 Harbin Pharmaceutical Group Swine Mycoplasma Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Harbin Pharmaceutical Group Main Business Overview
13.7.5 Harbin Pharmaceutical Group Latest Developments
13.8 Pulike Biotech
13.8.1 Pulike Biotech Company Information
13.8.2 Pulike Biotech Swine Mycoplasma Vaccine Product Portfolios and Specifications
13.8.3 Pulike Biotech Swine Mycoplasma Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Pulike Biotech Main Business Overview
13.8.5 Pulike Biotech Latest Developments
13.9 Qilu Animal Health Products
13.9.1 Qilu Animal Health Products Company Information
13.9.2 Qilu Animal Health Products Swine Mycoplasma Vaccine Product Portfolios and Specifications
13.9.3 Qilu Animal Health Products Swine Mycoplasma Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Qilu Animal Health Products Main Business Overview
13.9.5 Qilu Animal Health Products Latest Developments
13.10 Wuhan Keqian Biology
13.10.1 Wuhan Keqian Biology Company Information
13.10.2 Wuhan Keqian Biology Swine Mycoplasma Vaccine Product Portfolios and Specifications
13.10.3 Wuhan Keqian Biology Swine Mycoplasma Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Wuhan Keqian Biology Main Business Overview
13.10.5 Wuhan Keqian Biology Latest Developments
13.11 Guangdong Winsun Bio-Pharmaceutical
13.11.1 Guangdong Winsun Bio-Pharmaceutical Company Information
13.11.2 Guangdong Winsun Bio-Pharmaceutical Swine Mycoplasma Vaccine Product Portfolios and Specifications
13.11.3 Guangdong Winsun Bio-Pharmaceutical Swine Mycoplasma Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Guangdong Winsun Bio-Pharmaceutical Main Business Overview
13.11.5 Guangdong Winsun Bio-Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Swine Mycoplasma Vaccine Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Swine Mycoplasma Vaccine by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Swine Mycoplasma Vaccine by Country/Region, 2021, 2025 & 2032
2.2 Swine Mycoplasma Vaccine Segment by Type
2.2.1 Inactivated Vaccines
2.2.2 Live Vaccines
2.2.3 Swine Mycoplasma Vaccine Sales by Type
2.2.3.1 Global Swine Mycoplasma Vaccine Sales Market Share by Type (2021-2026)
2.2.3.2 Global Swine Mycoplasma Vaccine Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Swine Mycoplasma Vaccine Sale Price by Type (2021-2026)
2.3 Swine Mycoplasma Vaccine Segment by Application
2.3.1 Piglets
2.3.2 Adult Pigs
2.3.3 Swine Mycoplasma Vaccine Sales by Application
2.3.3.1 Global Swine Mycoplasma Vaccine Sale Market Share by Application (2021-2026)
2.3.3.2 Global Swine Mycoplasma Vaccine Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Swine Mycoplasma Vaccine Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Swine Mycoplasma Vaccine Breakdown Data by Company
3.1.1 Global Swine Mycoplasma Vaccine Annual Sales by Company (2021-2026)
3.1.2 Global Swine Mycoplasma Vaccine Sales Market Share by Company (2021-2026)
3.2 Global Swine Mycoplasma Vaccine Annual Revenue by Company (2021-2026)
3.2.1 Global Swine Mycoplasma Vaccine Revenue by Company (2021-2026)
3.2.2 Global Swine Mycoplasma Vaccine Revenue Market Share by Company (2021-2026)
3.3 Global Swine Mycoplasma Vaccine Sale Price by Company
3.4 Key Manufacturers Swine Mycoplasma Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Swine Mycoplasma Vaccine Product Location Distribution
3.4.2 Players Swine Mycoplasma Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR SWINE MYCOPLASMA VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Swine Mycoplasma Vaccine Market Size by Geographic Region (2021-2026)
4.1.1 Global Swine Mycoplasma Vaccine Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Swine Mycoplasma Vaccine Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Swine Mycoplasma Vaccine Market Size by Country/Region (2021-2026)
4.2.1 Global Swine Mycoplasma Vaccine Annual Sales by Country/Region (2021-2026)
4.2.2 Global Swine Mycoplasma Vaccine Annual Revenue by Country/Region (2021-2026)
4.3 Americas Swine Mycoplasma Vaccine Sales Growth
4.4 APAC Swine Mycoplasma Vaccine Sales Growth
4.5 Europe Swine Mycoplasma Vaccine Sales Growth
4.6 Middle East & Africa Swine Mycoplasma Vaccine Sales Growth
5 AMERICAS
5.1 Americas Swine Mycoplasma Vaccine Sales by Country
5.1.1 Americas Swine Mycoplasma Vaccine Sales by Country (2021-2026)
5.1.2 Americas Swine Mycoplasma Vaccine Revenue by Country (2021-2026)
5.2 Americas Swine Mycoplasma Vaccine Sales by Type (2021-2026)
5.3 Americas Swine Mycoplasma Vaccine Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Swine Mycoplasma Vaccine Sales by Region
6.1.1 APAC Swine Mycoplasma Vaccine Sales by Region (2021-2026)
6.1.2 APAC Swine Mycoplasma Vaccine Revenue by Region (2021-2026)
6.2 APAC Swine Mycoplasma Vaccine Sales by Type (2021-2026)
6.3 APAC Swine Mycoplasma Vaccine Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Swine Mycoplasma Vaccine by Country
7.1.1 Europe Swine Mycoplasma Vaccine Sales by Country (2021-2026)
7.1.2 Europe Swine Mycoplasma Vaccine Revenue by Country (2021-2026)
7.2 Europe Swine Mycoplasma Vaccine Sales by Type (2021-2026)
7.3 Europe Swine Mycoplasma Vaccine Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Swine Mycoplasma Vaccine by Country
8.1.1 Middle East & Africa Swine Mycoplasma Vaccine Sales by Country (2021-2026)
8.1.2 Middle East & Africa Swine Mycoplasma Vaccine Revenue by Country (2021-2026)
8.2 Middle East & Africa Swine Mycoplasma Vaccine Sales by Type (2021-2026)
8.3 Middle East & Africa Swine Mycoplasma Vaccine Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Swine Mycoplasma Vaccine
10.3 Manufacturing Process Analysis of Swine Mycoplasma Vaccine
10.4 Industry Chain Structure of Swine Mycoplasma Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Swine Mycoplasma Vaccine Distributors
11.3 Swine Mycoplasma Vaccine Customer
12 WORLD FORECAST REVIEW FOR SWINE MYCOPLASMA VACCINE BY GEOGRAPHIC REGION
12.1 Global Swine Mycoplasma Vaccine Market Size Forecast by Region
12.1.1 Global Swine Mycoplasma Vaccine Forecast by Region (2027-2032)
12.1.2 Global Swine Mycoplasma Vaccine Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Swine Mycoplasma Vaccine Forecast by Type (2027-2032)
12.7 Global Swine Mycoplasma Vaccine Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Zoetis
13.1.1 Zoetis Company Information
13.1.2 Zoetis Swine Mycoplasma Vaccine Product Portfolios and Specifications
13.1.3 Zoetis Swine Mycoplasma Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Zoetis Main Business Overview
13.1.5 Zoetis Latest Developments
13.2 Boehringer Ingelheim
13.2.1 Boehringer Ingelheim Company Information
13.2.2 Boehringer Ingelheim Swine Mycoplasma Vaccine Product Portfolios and Specifications
13.2.3 Boehringer Ingelheim Swine Mycoplasma Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Boehringer Ingelheim Main Business Overview
13.2.5 Boehringer Ingelheim Latest Developments
13.3 Jinhe Biotechnology
13.3.1 Jinhe Biotechnology Company Information
13.3.2 Jinhe Biotechnology Swine Mycoplasma Vaccine Product Portfolios and Specifications
13.3.3 Jinhe Biotechnology Swine Mycoplasma Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Jinhe Biotechnology Main Business Overview
13.3.5 Jinhe Biotechnology Latest Developments
13.4 Merck
13.4.1 Merck Company Information
13.4.2 Merck Swine Mycoplasma Vaccine Product Portfolios and Specifications
13.4.3 Merck Swine Mycoplasma Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Merck Main Business Overview
13.4.5 Merck Latest Developments
13.5 HIPRA
13.5.1 HIPRA Company Information
13.5.2 HIPRA Swine Mycoplasma Vaccine Product Portfolios and Specifications
13.5.3 HIPRA Swine Mycoplasma Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 HIPRA Main Business Overview
13.5.5 HIPRA Latest Developments
13.6 Ceva Sant? Animale
13.6.1 Ceva Sant? Animale Company Information
13.6.2 Ceva Sant? Animale Swine Mycoplasma Vaccine Product Portfolios and Specifications
13.6.3 Ceva Sant? Animale Swine Mycoplasma Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Ceva Sant? Animale Main Business Overview
13.6.5 Ceva Sant? Animale Latest Developments
13.7 Harbin Pharmaceutical Group
13.7.1 Harbin Pharmaceutical Group Company Information
13.7.2 Harbin Pharmaceutical Group Swine Mycoplasma Vaccine Product Portfolios and Specifications
13.7.3 Harbin Pharmaceutical Group Swine Mycoplasma Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Harbin Pharmaceutical Group Main Business Overview
13.7.5 Harbin Pharmaceutical Group Latest Developments
13.8 Pulike Biotech
13.8.1 Pulike Biotech Company Information
13.8.2 Pulike Biotech Swine Mycoplasma Vaccine Product Portfolios and Specifications
13.8.3 Pulike Biotech Swine Mycoplasma Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Pulike Biotech Main Business Overview
13.8.5 Pulike Biotech Latest Developments
13.9 Qilu Animal Health Products
13.9.1 Qilu Animal Health Products Company Information
13.9.2 Qilu Animal Health Products Swine Mycoplasma Vaccine Product Portfolios and Specifications
13.9.3 Qilu Animal Health Products Swine Mycoplasma Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Qilu Animal Health Products Main Business Overview
13.9.5 Qilu Animal Health Products Latest Developments
13.10 Wuhan Keqian Biology
13.10.1 Wuhan Keqian Biology Company Information
13.10.2 Wuhan Keqian Biology Swine Mycoplasma Vaccine Product Portfolios and Specifications
13.10.3 Wuhan Keqian Biology Swine Mycoplasma Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Wuhan Keqian Biology Main Business Overview
13.10.5 Wuhan Keqian Biology Latest Developments
13.11 Guangdong Winsun Bio-Pharmaceutical
13.11.1 Guangdong Winsun Bio-Pharmaceutical Company Information
13.11.2 Guangdong Winsun Bio-Pharmaceutical Swine Mycoplasma Vaccine Product Portfolios and Specifications
13.11.3 Guangdong Winsun Bio-Pharmaceutical Swine Mycoplasma Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Guangdong Winsun Bio-Pharmaceutical Main Business Overview
13.11.5 Guangdong Winsun Bio-Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Swine Mycoplasma Vaccine Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Swine Mycoplasma Vaccine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Inactivated Vaccines
Table 4. Major Players of Live Vaccines
Table 5. Global Swine Mycoplasma Vaccine Sales by Type (2021-2026) & (K Units)
Table 6. Global Swine Mycoplasma Vaccine Sales Market Share by Type (2021-2026)
Table 7. Global Swine Mycoplasma Vaccine Revenue by Type (2021-2026) & ($ million)
Table 8. Global Swine Mycoplasma Vaccine Revenue Market Share by Type (2021-2026)
Table 9. Global Swine Mycoplasma Vaccine Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Swine Mycoplasma Vaccine Sale by Application (2021-2026) & (K Units)
Table 11. Global Swine Mycoplasma Vaccine Sale Market Share by Application (2021-2026)
Table 12. Global Swine Mycoplasma Vaccine Revenue by Application (2021-2026) & ($ million)
Table 13. Global Swine Mycoplasma Vaccine Revenue Market Share by Application (2021-2026)
Table 14. Global Swine Mycoplasma Vaccine Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Swine Mycoplasma Vaccine Sales by Company (2021-2026) & (K Units)
Table 16. Global Swine Mycoplasma Vaccine Sales Market Share by Company (2021-2026)
Table 17. Global Swine Mycoplasma Vaccine Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Swine Mycoplasma Vaccine Revenue Market Share by Company (2021-2026)
Table 19. Global Swine Mycoplasma Vaccine Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Swine Mycoplasma Vaccine Producing Area Distribution and Sales Area
Table 21. Players Swine Mycoplasma Vaccine Products Offered
Table 22. Swine Mycoplasma Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Swine Mycoplasma Vaccine Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Swine Mycoplasma Vaccine Sales Market Share Geographic Region (2021-2026)
Table 27. Global Swine Mycoplasma Vaccine Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Swine Mycoplasma Vaccine Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Swine Mycoplasma Vaccine Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Swine Mycoplasma Vaccine Sales Market Share by Country/Region (2021-2026)
Table 31. Global Swine Mycoplasma Vaccine Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Swine Mycoplasma Vaccine Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Swine Mycoplasma Vaccine Sales by Country (2021-2026) & (K Units)
Table 34. Americas Swine Mycoplasma Vaccine Sales Market Share by Country (2021-2026)
Table 35. Americas Swine Mycoplasma Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Swine Mycoplasma Vaccine Sales by Type (2021-2026) & (K Units)
Table 37. Americas Swine Mycoplasma Vaccine Sales by Application (2021-2026) & (K Units)
Table 38. APAC Swine Mycoplasma Vaccine Sales by Region (2021-2026) & (K Units)
Table 39. APAC Swine Mycoplasma Vaccine Sales Market Share by Region (2021-2026)
Table 40. APAC Swine Mycoplasma Vaccine Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Swine Mycoplasma Vaccine Sales by Type (2021-2026) & (K Units)
Table 42. APAC Swine Mycoplasma Vaccine Sales by Application (2021-2026) & (K Units)
Table 43. Europe Swine Mycoplasma Vaccine Sales by Country (2021-2026) & (K Units)
Table 44. Europe Swine Mycoplasma Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Swine Mycoplasma Vaccine Sales by Type (2021-2026) & (K Units)
Table 46. Europe Swine Mycoplasma Vaccine Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Swine Mycoplasma Vaccine Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Swine Mycoplasma Vaccine Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Swine Mycoplasma Vaccine Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Swine Mycoplasma Vaccine Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Swine Mycoplasma Vaccine
Table 52. Key Market Challenges & Risks of Swine Mycoplasma Vaccine
Table 53. Key Industry Trends of Swine Mycoplasma Vaccine
Table 54. Swine Mycoplasma Vaccine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Swine Mycoplasma Vaccine Distributors List
Table 57. Swine Mycoplasma Vaccine Customer List
Table 58. Global Swine Mycoplasma Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Swine Mycoplasma Vaccine Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Swine Mycoplasma Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Swine Mycoplasma Vaccine Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Swine Mycoplasma Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Swine Mycoplasma Vaccine Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Swine Mycoplasma Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Swine Mycoplasma Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Swine Mycoplasma Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Swine Mycoplasma Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Swine Mycoplasma Vaccine Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Swine Mycoplasma Vaccine Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Swine Mycoplasma Vaccine Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Swine Mycoplasma Vaccine Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Zoetis Basic Information, Swine Mycoplasma Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 73. Zoetis Swine Mycoplasma Vaccine Product Portfolios and Specifications
Table 74. Zoetis Swine Mycoplasma Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Zoetis Main Business
Table 76. Zoetis Latest Developments
Table 77. Boehringer Ingelheim Basic Information, Swine Mycoplasma Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 78. Boehringer Ingelheim Swine Mycoplasma Vaccine Product Portfolios and Specifications
Table 79. Boehringer Ingelheim Swine Mycoplasma Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Boehringer Ingelheim Main Business
Table 81. Boehringer Ingelheim Latest Developments
Table 82. Jinhe Biotechnology Basic Information, Swine Mycoplasma Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 83. Jinhe Biotechnology Swine Mycoplasma Vaccine Product Portfolios and Specifications
Table 84. Jinhe Biotechnology Swine Mycoplasma Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Jinhe Biotechnology Main Business
Table 86. Jinhe Biotechnology Latest Developments
Table 87. Merck Basic Information, Swine Mycoplasma Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 88. Merck Swine Mycoplasma Vaccine Product Portfolios and Specifications
Table 89. Merck Swine Mycoplasma Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Merck Main Business
Table 91. Merck Latest Developments
Table 92. HIPRA Basic Information, Swine Mycoplasma Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. HIPRA Swine Mycoplasma Vaccine Product Portfolios and Specifications
Table 94. HIPRA Swine Mycoplasma Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. HIPRA Main Business
Table 96. HIPRA Latest Developments
Table 97. Ceva Sant? Animale Basic Information, Swine Mycoplasma Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. Ceva Sant? Animale Swine Mycoplasma Vaccine Product Portfolios and Specifications
Table 99. Ceva Sant? Animale Swine Mycoplasma Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Ceva Sant? Animale Main Business
Table 101. Ceva Sant? Animale Latest Developments
Table 102. Harbin Pharmaceutical Group Basic Information, Swine Mycoplasma Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. Harbin Pharmaceutical Group Swine Mycoplasma Vaccine Product Portfolios and Specifications
Table 104. Harbin Pharmaceutical Group Swine Mycoplasma Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Harbin Pharmaceutical Group Main Business
Table 106. Harbin Pharmaceutical Group Latest Developments
Table 107. Pulike Biotech Basic Information, Swine Mycoplasma Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 108. Pulike Biotech Swine Mycoplasma Vaccine Product Portfolios and Specifications
Table 109. Pulike Biotech Swine Mycoplasma Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Pulike Biotech Main Business
Table 111. Pulike Biotech Latest Developments
Table 112. Qilu Animal Health Products Basic Information, Swine Mycoplasma Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 113. Qilu Animal Health Products Swine Mycoplasma Vaccine Product Portfolios and Specifications
Table 114. Qilu Animal Health Products Swine Mycoplasma Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Qilu Animal Health Products Main Business
Table 116. Qilu Animal Health Products Latest Developments
Table 117. Wuhan Keqian Biology Basic Information, Swine Mycoplasma Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 118. Wuhan Keqian Biology Swine Mycoplasma Vaccine Product Portfolios and Specifications
Table 119. Wuhan Keqian Biology Swine Mycoplasma Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Wuhan Keqian Biology Main Business
Table 121. Wuhan Keqian Biology Latest Developments
Table 122. Guangdong Winsun Bio-Pharmaceutical Basic Information, Swine Mycoplasma Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 123. Guangdong Winsun Bio-Pharmaceutical Swine Mycoplasma Vaccine Product Portfolios and Specifications
Table 124. Guangdong Winsun Bio-Pharmaceutical Swine Mycoplasma Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Guangdong Winsun Bio-Pharmaceutical Main Business
Table 126. Guangdong Winsun Bio-Pharmaceutical Latest Developments
Table 1. Swine Mycoplasma Vaccine Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Swine Mycoplasma Vaccine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Inactivated Vaccines
Table 4. Major Players of Live Vaccines
Table 5. Global Swine Mycoplasma Vaccine Sales by Type (2021-2026) & (K Units)
Table 6. Global Swine Mycoplasma Vaccine Sales Market Share by Type (2021-2026)
Table 7. Global Swine Mycoplasma Vaccine Revenue by Type (2021-2026) & ($ million)
Table 8. Global Swine Mycoplasma Vaccine Revenue Market Share by Type (2021-2026)
Table 9. Global Swine Mycoplasma Vaccine Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Swine Mycoplasma Vaccine Sale by Application (2021-2026) & (K Units)
Table 11. Global Swine Mycoplasma Vaccine Sale Market Share by Application (2021-2026)
Table 12. Global Swine Mycoplasma Vaccine Revenue by Application (2021-2026) & ($ million)
Table 13. Global Swine Mycoplasma Vaccine Revenue Market Share by Application (2021-2026)
Table 14. Global Swine Mycoplasma Vaccine Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Swine Mycoplasma Vaccine Sales by Company (2021-2026) & (K Units)
Table 16. Global Swine Mycoplasma Vaccine Sales Market Share by Company (2021-2026)
Table 17. Global Swine Mycoplasma Vaccine Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Swine Mycoplasma Vaccine Revenue Market Share by Company (2021-2026)
Table 19. Global Swine Mycoplasma Vaccine Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Swine Mycoplasma Vaccine Producing Area Distribution and Sales Area
Table 21. Players Swine Mycoplasma Vaccine Products Offered
Table 22. Swine Mycoplasma Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Swine Mycoplasma Vaccine Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Swine Mycoplasma Vaccine Sales Market Share Geographic Region (2021-2026)
Table 27. Global Swine Mycoplasma Vaccine Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Swine Mycoplasma Vaccine Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Swine Mycoplasma Vaccine Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Swine Mycoplasma Vaccine Sales Market Share by Country/Region (2021-2026)
Table 31. Global Swine Mycoplasma Vaccine Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Swine Mycoplasma Vaccine Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Swine Mycoplasma Vaccine Sales by Country (2021-2026) & (K Units)
Table 34. Americas Swine Mycoplasma Vaccine Sales Market Share by Country (2021-2026)
Table 35. Americas Swine Mycoplasma Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Swine Mycoplasma Vaccine Sales by Type (2021-2026) & (K Units)
Table 37. Americas Swine Mycoplasma Vaccine Sales by Application (2021-2026) & (K Units)
Table 38. APAC Swine Mycoplasma Vaccine Sales by Region (2021-2026) & (K Units)
Table 39. APAC Swine Mycoplasma Vaccine Sales Market Share by Region (2021-2026)
Table 40. APAC Swine Mycoplasma Vaccine Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Swine Mycoplasma Vaccine Sales by Type (2021-2026) & (K Units)
Table 42. APAC Swine Mycoplasma Vaccine Sales by Application (2021-2026) & (K Units)
Table 43. Europe Swine Mycoplasma Vaccine Sales by Country (2021-2026) & (K Units)
Table 44. Europe Swine Mycoplasma Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Swine Mycoplasma Vaccine Sales by Type (2021-2026) & (K Units)
Table 46. Europe Swine Mycoplasma Vaccine Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Swine Mycoplasma Vaccine Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Swine Mycoplasma Vaccine Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Swine Mycoplasma Vaccine Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Swine Mycoplasma Vaccine Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Swine Mycoplasma Vaccine
Table 52. Key Market Challenges & Risks of Swine Mycoplasma Vaccine
Table 53. Key Industry Trends of Swine Mycoplasma Vaccine
Table 54. Swine Mycoplasma Vaccine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Swine Mycoplasma Vaccine Distributors List
Table 57. Swine Mycoplasma Vaccine Customer List
Table 58. Global Swine Mycoplasma Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Swine Mycoplasma Vaccine Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Swine Mycoplasma Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Swine Mycoplasma Vaccine Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Swine Mycoplasma Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Swine Mycoplasma Vaccine Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Swine Mycoplasma Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Swine Mycoplasma Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Swine Mycoplasma Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Swine Mycoplasma Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Swine Mycoplasma Vaccine Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Swine Mycoplasma Vaccine Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Swine Mycoplasma Vaccine Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Swine Mycoplasma Vaccine Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Zoetis Basic Information, Swine Mycoplasma Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 73. Zoetis Swine Mycoplasma Vaccine Product Portfolios and Specifications
Table 74. Zoetis Swine Mycoplasma Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Zoetis Main Business
Table 76. Zoetis Latest Developments
Table 77. Boehringer Ingelheim Basic Information, Swine Mycoplasma Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 78. Boehringer Ingelheim Swine Mycoplasma Vaccine Product Portfolios and Specifications
Table 79. Boehringer Ingelheim Swine Mycoplasma Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Boehringer Ingelheim Main Business
Table 81. Boehringer Ingelheim Latest Developments
Table 82. Jinhe Biotechnology Basic Information, Swine Mycoplasma Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 83. Jinhe Biotechnology Swine Mycoplasma Vaccine Product Portfolios and Specifications
Table 84. Jinhe Biotechnology Swine Mycoplasma Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Jinhe Biotechnology Main Business
Table 86. Jinhe Biotechnology Latest Developments
Table 87. Merck Basic Information, Swine Mycoplasma Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 88. Merck Swine Mycoplasma Vaccine Product Portfolios and Specifications
Table 89. Merck Swine Mycoplasma Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Merck Main Business
Table 91. Merck Latest Developments
Table 92. HIPRA Basic Information, Swine Mycoplasma Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. HIPRA Swine Mycoplasma Vaccine Product Portfolios and Specifications
Table 94. HIPRA Swine Mycoplasma Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. HIPRA Main Business
Table 96. HIPRA Latest Developments
Table 97. Ceva Sant? Animale Basic Information, Swine Mycoplasma Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. Ceva Sant? Animale Swine Mycoplasma Vaccine Product Portfolios and Specifications
Table 99. Ceva Sant? Animale Swine Mycoplasma Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Ceva Sant? Animale Main Business
Table 101. Ceva Sant? Animale Latest Developments
Table 102. Harbin Pharmaceutical Group Basic Information, Swine Mycoplasma Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. Harbin Pharmaceutical Group Swine Mycoplasma Vaccine Product Portfolios and Specifications
Table 104. Harbin Pharmaceutical Group Swine Mycoplasma Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Harbin Pharmaceutical Group Main Business
Table 106. Harbin Pharmaceutical Group Latest Developments
Table 107. Pulike Biotech Basic Information, Swine Mycoplasma Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 108. Pulike Biotech Swine Mycoplasma Vaccine Product Portfolios and Specifications
Table 109. Pulike Biotech Swine Mycoplasma Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Pulike Biotech Main Business
Table 111. Pulike Biotech Latest Developments
Table 112. Qilu Animal Health Products Basic Information, Swine Mycoplasma Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 113. Qilu Animal Health Products Swine Mycoplasma Vaccine Product Portfolios and Specifications
Table 114. Qilu Animal Health Products Swine Mycoplasma Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Qilu Animal Health Products Main Business
Table 116. Qilu Animal Health Products Latest Developments
Table 117. Wuhan Keqian Biology Basic Information, Swine Mycoplasma Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 118. Wuhan Keqian Biology Swine Mycoplasma Vaccine Product Portfolios and Specifications
Table 119. Wuhan Keqian Biology Swine Mycoplasma Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Wuhan Keqian Biology Main Business
Table 121. Wuhan Keqian Biology Latest Developments
Table 122. Guangdong Winsun Bio-Pharmaceutical Basic Information, Swine Mycoplasma Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 123. Guangdong Winsun Bio-Pharmaceutical Swine Mycoplasma Vaccine Product Portfolios and Specifications
Table 124. Guangdong Winsun Bio-Pharmaceutical Swine Mycoplasma Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Guangdong Winsun Bio-Pharmaceutical Main Business
Table 126. Guangdong Winsun Bio-Pharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. Picture of Swine Mycoplasma Vaccine
Figure 2. Swine Mycoplasma Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Swine Mycoplasma Vaccine Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Swine Mycoplasma Vaccine Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Swine Mycoplasma Vaccine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Swine Mycoplasma Vaccine Sales Market Share by Country/Region (2025)
Figure 10. Swine Mycoplasma Vaccine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Inactivated Vaccines
Figure 12. Product Picture of Live Vaccines
Figure 13. Global Swine Mycoplasma Vaccine Sales Market Share by Type in 2026
Figure 14. Global Swine Mycoplasma Vaccine Revenue Market Share by Type (2021-2026)
Figure 15. Swine Mycoplasma Vaccine Consumed in Piglets
Figure 16. Global Swine Mycoplasma Vaccine Market: Piglets (2021-2026) & (K Units)
Figure 17. Swine Mycoplasma Vaccine Consumed in Adult Pigs
Figure 18. Global Swine Mycoplasma Vaccine Market: Adult Pigs (2021-2026) & (K Units)
Figure 19. Global Swine Mycoplasma Vaccine Sale Market Share by Application (2025)
Figure 20. Global Swine Mycoplasma Vaccine Revenue Market Share by Application in 2026
Figure 21. Swine Mycoplasma Vaccine Sales by Company in 2026 (K Units)
Figure 22. Global Swine Mycoplasma Vaccine Sales Market Share by Company in 2026
Figure 23. Swine Mycoplasma Vaccine Revenue by Company in 2026 ($ millions)
Figure 24. Global Swine Mycoplasma Vaccine Revenue Market Share by Company in 2026
Figure 25. Global Swine Mycoplasma Vaccine Sales Market Share by Geographic Region (2021-2026)
Figure 26. Global Swine Mycoplasma Vaccine Revenue Market Share by Geographic Region in 2026
Figure 27. Americas Swine Mycoplasma Vaccine Sales 2021-2026 (K Units)
Figure 28. Americas Swine Mycoplasma Vaccine Revenue 2021-2026 ($ millions)
Figure 29. APAC Swine Mycoplasma Vaccine Sales 2021-2026 (K Units)
Figure 30. APAC Swine Mycoplasma Vaccine Revenue 2021-2026 ($ millions)
Figure 31. Europe Swine Mycoplasma Vaccine Sales 2021-2026 (K Units)
Figure 32. Europe Swine Mycoplasma Vaccine Revenue 2021-2026 ($ millions)
Figure 33. Middle East & Africa Swine Mycoplasma Vaccine Sales 2021-2026 (K Units)
Figure 34. Middle East & Africa Swine Mycoplasma Vaccine Revenue 2021-2026 ($ millions)
Figure 35. Americas Swine Mycoplasma Vaccine Sales Market Share by Country in 2026
Figure 36. Americas Swine Mycoplasma Vaccine Revenue Market Share by Country (2021-2026)
Figure 37. Americas Swine Mycoplasma Vaccine Sales Market Share by Type (2021-2026)
Figure 38. Americas Swine Mycoplasma Vaccine Sales Market Share by Application (2021-2026)
Figure 39. United States Swine Mycoplasma Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 40. Canada Swine Mycoplasma Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 41. Mexico Swine Mycoplasma Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 42. Brazil Swine Mycoplasma Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 43. APAC Swine Mycoplasma Vaccine Sales Market Share by Region in 2026
Figure 44. APAC Swine Mycoplasma Vaccine Revenue Market Share by Region (2021-2026)
Figure 45. APAC Swine Mycoplasma Vaccine Sales Market Share by Type (2021-2026)
Figure 46. APAC Swine Mycoplasma Vaccine Sales Market Share by Application (2021-2026)
Figure 47. China Swine Mycoplasma Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 48. Japan Swine Mycoplasma Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 49. South Korea Swine Mycoplasma Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 50. Southeast Asia Swine Mycoplasma Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 51. India Swine Mycoplasma Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 52. Australia Swine Mycoplasma Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 53. China Taiwan Swine Mycoplasma Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 54. Europe Swine Mycoplasma Vaccine Sales Market Share by Country in 2026
Figure 55. Europe Swine Mycoplasma Vaccine Revenue Market Share by Country (2021-2026)
Figure 56. Europe Swine Mycoplasma Vaccine Sales Market Share by Type (2021-2026)
Figure 57. Europe Swine Mycoplasma Vaccine Sales Market Share by Application (2021-2026)
Figure 58. Germany Swine Mycoplasma Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 59. France Swine Mycoplasma Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 60. UK Swine Mycoplasma Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 61. Italy Swine Mycoplasma Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 62. Russia Swine Mycoplasma Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 63. Middle East & Africa Swine Mycoplasma Vaccine Sales Market Share by Country (2021-2026)
Figure 64. Middle East & Africa Swine Mycoplasma Vaccine Sales Market Share by Type (2021-2026)
Figure 65. Middle East & Africa Swine Mycoplasma Vaccine Sales Market Share by Application (2021-2026)
Figure 66. Egypt Swine Mycoplasma Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 67. South Africa Swine Mycoplasma Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 68. Israel Swine Mycoplasma Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 69. Turkey Swine Mycoplasma Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 70. GCC Countries Swine Mycoplasma Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Swine Mycoplasma Vaccine in 2026
Figure 72. Manufacturing Process Analysis of Swine Mycoplasma Vaccine
Figure 73. Industry Chain Structure of Swine Mycoplasma Vaccine
Figure 74. Channels of Distribution
Figure 75. Global Swine Mycoplasma Vaccine Sales Market Forecast by Region (2027-2032)
Figure 76. Global Swine Mycoplasma Vaccine Revenue Market Share Forecast by Region (2027-2032)
Figure 77. Global Swine Mycoplasma Vaccine Sales Market Share Forecast by Type (2027-2032)
Figure 78. Global Swine Mycoplasma Vaccine Revenue Market Share Forecast by Type (2027-2032)
Figure 79. Global Swine Mycoplasma Vaccine Sales Market Share Forecast by Application (2027-2032)
Figure 80. Global Swine Mycoplasma Vaccine Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Swine Mycoplasma Vaccine
Figure 2. Swine Mycoplasma Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Swine Mycoplasma Vaccine Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Swine Mycoplasma Vaccine Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Swine Mycoplasma Vaccine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Swine Mycoplasma Vaccine Sales Market Share by Country/Region (2025)
Figure 10. Swine Mycoplasma Vaccine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Inactivated Vaccines
Figure 12. Product Picture of Live Vaccines
Figure 13. Global Swine Mycoplasma Vaccine Sales Market Share by Type in 2026
Figure 14. Global Swine Mycoplasma Vaccine Revenue Market Share by Type (2021-2026)
Figure 15. Swine Mycoplasma Vaccine Consumed in Piglets
Figure 16. Global Swine Mycoplasma Vaccine Market: Piglets (2021-2026) & (K Units)
Figure 17. Swine Mycoplasma Vaccine Consumed in Adult Pigs
Figure 18. Global Swine Mycoplasma Vaccine Market: Adult Pigs (2021-2026) & (K Units)
Figure 19. Global Swine Mycoplasma Vaccine Sale Market Share by Application (2025)
Figure 20. Global Swine Mycoplasma Vaccine Revenue Market Share by Application in 2026
Figure 21. Swine Mycoplasma Vaccine Sales by Company in 2026 (K Units)
Figure 22. Global Swine Mycoplasma Vaccine Sales Market Share by Company in 2026
Figure 23. Swine Mycoplasma Vaccine Revenue by Company in 2026 ($ millions)
Figure 24. Global Swine Mycoplasma Vaccine Revenue Market Share by Company in 2026
Figure 25. Global Swine Mycoplasma Vaccine Sales Market Share by Geographic Region (2021-2026)
Figure 26. Global Swine Mycoplasma Vaccine Revenue Market Share by Geographic Region in 2026
Figure 27. Americas Swine Mycoplasma Vaccine Sales 2021-2026 (K Units)
Figure 28. Americas Swine Mycoplasma Vaccine Revenue 2021-2026 ($ millions)
Figure 29. APAC Swine Mycoplasma Vaccine Sales 2021-2026 (K Units)
Figure 30. APAC Swine Mycoplasma Vaccine Revenue 2021-2026 ($ millions)
Figure 31. Europe Swine Mycoplasma Vaccine Sales 2021-2026 (K Units)
Figure 32. Europe Swine Mycoplasma Vaccine Revenue 2021-2026 ($ millions)
Figure 33. Middle East & Africa Swine Mycoplasma Vaccine Sales 2021-2026 (K Units)
Figure 34. Middle East & Africa Swine Mycoplasma Vaccine Revenue 2021-2026 ($ millions)
Figure 35. Americas Swine Mycoplasma Vaccine Sales Market Share by Country in 2026
Figure 36. Americas Swine Mycoplasma Vaccine Revenue Market Share by Country (2021-2026)
Figure 37. Americas Swine Mycoplasma Vaccine Sales Market Share by Type (2021-2026)
Figure 38. Americas Swine Mycoplasma Vaccine Sales Market Share by Application (2021-2026)
Figure 39. United States Swine Mycoplasma Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 40. Canada Swine Mycoplasma Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 41. Mexico Swine Mycoplasma Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 42. Brazil Swine Mycoplasma Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 43. APAC Swine Mycoplasma Vaccine Sales Market Share by Region in 2026
Figure 44. APAC Swine Mycoplasma Vaccine Revenue Market Share by Region (2021-2026)
Figure 45. APAC Swine Mycoplasma Vaccine Sales Market Share by Type (2021-2026)
Figure 46. APAC Swine Mycoplasma Vaccine Sales Market Share by Application (2021-2026)
Figure 47. China Swine Mycoplasma Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 48. Japan Swine Mycoplasma Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 49. South Korea Swine Mycoplasma Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 50. Southeast Asia Swine Mycoplasma Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 51. India Swine Mycoplasma Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 52. Australia Swine Mycoplasma Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 53. China Taiwan Swine Mycoplasma Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 54. Europe Swine Mycoplasma Vaccine Sales Market Share by Country in 2026
Figure 55. Europe Swine Mycoplasma Vaccine Revenue Market Share by Country (2021-2026)
Figure 56. Europe Swine Mycoplasma Vaccine Sales Market Share by Type (2021-2026)
Figure 57. Europe Swine Mycoplasma Vaccine Sales Market Share by Application (2021-2026)
Figure 58. Germany Swine Mycoplasma Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 59. France Swine Mycoplasma Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 60. UK Swine Mycoplasma Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 61. Italy Swine Mycoplasma Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 62. Russia Swine Mycoplasma Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 63. Middle East & Africa Swine Mycoplasma Vaccine Sales Market Share by Country (2021-2026)
Figure 64. Middle East & Africa Swine Mycoplasma Vaccine Sales Market Share by Type (2021-2026)
Figure 65. Middle East & Africa Swine Mycoplasma Vaccine Sales Market Share by Application (2021-2026)
Figure 66. Egypt Swine Mycoplasma Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 67. South Africa Swine Mycoplasma Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 68. Israel Swine Mycoplasma Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 69. Turkey Swine Mycoplasma Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 70. GCC Countries Swine Mycoplasma Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Swine Mycoplasma Vaccine in 2026
Figure 72. Manufacturing Process Analysis of Swine Mycoplasma Vaccine
Figure 73. Industry Chain Structure of Swine Mycoplasma Vaccine
Figure 74. Channels of Distribution
Figure 75. Global Swine Mycoplasma Vaccine Sales Market Forecast by Region (2027-2032)
Figure 76. Global Swine Mycoplasma Vaccine Revenue Market Share Forecast by Region (2027-2032)
Figure 77. Global Swine Mycoplasma Vaccine Sales Market Share Forecast by Type (2027-2032)
Figure 78. Global Swine Mycoplasma Vaccine Revenue Market Share Forecast by Type (2027-2032)
Figure 79. Global Swine Mycoplasma Vaccine Sales Market Share Forecast by Application (2027-2032)
Figure 80. Global Swine Mycoplasma Vaccine Revenue Market Share Forecast by Application (2027-2032)
